Clarus Therapeutics Holdings Inc (CRXT)

NASDAQ
0.38
0.00(0.29%)
After Hours
0.40
+0.01(+3.34%)
- Real-time Data
  • Volume:
    1,374,209
  • Day's Range:
    0.36 - 0.40
  • 52 wk Range:
    0.33 - 31.24

CRXT Overview

Prev. Close
0.38
Day's Range
0.36-0.4
Revenue
17.97M
Open
0.38
52 wk Range
0.33-31.24
EPS
-1.51
Volume
1,374,209
Market Cap
19.93M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
13,729,753
P/E Ratio
-
Beta
-
1-Year Change
-96.2%
Shares Outstanding
52,020,731
Next Earnings Date
Aug 31, 2022
What is your sentiment on Clarus Therapeutics Holdings?
or
Market is currently closed. Voting is open during market hours.

Clarus Therapeutics Holdings Inc News

Clarus Therapeutics Holdings Inc Company Profile

Clarus Therapeutics Holdings Inc Company Profile

Employees
16

Clarus Therapeutics Holdings, Inc., a pharmaceutical company, focuses on the development and commercialization of oral testosterone replacement therapy in the United States. It offers JATENZO, a soft gel oral formulation of testosterone undecanoate for treating hypogonadal men. The company has a licensing agreement with HavaH Therapeutics for product to treat androgen therapies for inflammatory breast disease and certain forms of breast cancer; and license agreement with The Royal Institution for the Advancement of Learning/McGill University to develop and commercialize McGill’s proprietary technology designed to treat conditions associated with CoQ10 deficiencies in humans. Clarus Therapeutics Holdings, Inc. was founded in 2003 and is based in Northbrook, Illinois.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellStrong SellStrong SellStrong SellStrong Sell
Technical IndicatorsSellSellBuyStrong SellSell
SummaryStrong SellStrong SellNeutralStrong SellStrong Sell
  • If it breaks 2,6 then we move back to 4
    0
    • Up up
      0
      • Krazy
        0
        • Scam
          0
          • why Securities and Exchange Commission do nothing?
            0